04.01.2024 - SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) - Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that its board of directors (Board) has . Seite 1